These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7640234)

  • 21. Adjuvant chemotherapy of adult patients with soft tissue sarcomas.
    Rosenberg SA
    Important Adv Oncol; 1985; ():273-94. PubMed ID: 3916745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surrogacy of intermediate endpoints for overall survival in randomized controlled trials of first-line treatment for advanced soft tissue sarcoma in the pre- and post-pazopanib era: a meta-analytic evaluation.
    Tanaka K; Kawano M; Iwasaki T; Itonaga I; Tsumura H
    BMC Cancer; 2019 Jan; 19(1):56. PubMed ID: 30634944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
    Bramwell V; Rouesse J; Steward W; Santoro A; Schraffordt-Koops H; Buesa J; Ruka W; Priario J; Wagener T; Burgers M
    J Clin Oncol; 1994 Jun; 12(6):1137-49. PubMed ID: 8201375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Call for improved design and reporting in soft tissue sarcoma studies: A systematic review and meta-analysis of chemotherapy and survival outcomes in resectable STS.
    Istl AC; Ruck JM; Morris CD; Levin AS; Meyer CF; Johnston FM
    J Surg Oncol; 2019 Jun; 119(7):824-835. PubMed ID: 30737793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chemotherapy for soft tissue sarcoma--current concepts and review].
    Umeda T; Ishii T; Hatakeyama K; Wakita H
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):1937-44. PubMed ID: 8215466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant therapy for high-risk soft tissue sarcoma in the adult.
    Gronchi A; Casali PG
    Curr Treat Options Oncol; 2013 Sep; 14(3):415-24. PubMed ID: 23775297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant chemotherapy in the treatment of soft-tissue sarcoma.
    Mertens WC; Bramwell VH
    Clin Orthop Relat Res; 1993 Apr; (289):81-93. PubMed ID: 8472435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes.
    Cormier JN; Huang X; Xing Y; Thall PF; Wang X; Benjamin RS; Pollock RE; Antonescu CR; Maki RG; Brennan MF; Pisters PW
    J Clin Oncol; 2004 Nov; 22(22):4567-74. PubMed ID: 15542808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant chemotherapy of soft tissue sarcomas.
    Verweij J; Pinedo HM
    Cancer Treat Res; 1997; 91():173-87. PubMed ID: 9286496
    [No Abstract]   [Full Text] [Related]  

  • 30. Regional hyperthermia for high-risk soft tissue sarcoma treatment: present status and next questions.
    Issels R; Lindner LH
    Curr Opin Oncol; 2016 Sep; 28(5):447-52. PubMed ID: 27455134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.
    Judson I; Verweij J; Gelderblom H; Hartmann JT; Schöffski P; Blay JY; Kerst JM; Sufliarsky J; Whelan J; Hohenberger P; Krarup-Hansen A; Alcindor T; Marreaud S; Litière S; Hermans C; Fisher C; Hogendoorn PC; dei Tos AP; van der Graaf WT;
    Lancet Oncol; 2014 Apr; 15(4):415-23. PubMed ID: 24618336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX).
    Sundby Hall K; Bruland ØS; Bjerkehagen B; Zaikova O; Engellau J; Hagberg O; Hansson L; Hagberg H; Ahlström M; Knobel H; Papworth K; Zemmler M; Goplen D; Bauer HCF; Eriksson M
    Eur J Cancer; 2018 Aug; 99():78-85. PubMed ID: 29929092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial.
    Tap WD; Jones RL; Van Tine BA; Chmielowski B; Elias AD; Adkins D; Agulnik M; Cooney MM; Livingston MB; Pennock G; Hameed MR; Shah GD; Qin A; Shahir A; Cronier DM; Ilaria R; Conti I; Cosaert J; Schwartz GK
    Lancet; 2016 Jul; 388(10043):488-97. PubMed ID: 27291997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in chemotherapy for patients with extremity soft tissue sarcoma.
    Eilber FC; Tap WD; Nelson SD; Eckardt JJ; Eilber FR
    Orthop Clin North Am; 2006 Jan; 37(1):15-22. PubMed ID: 16311108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New concepts for the treatment of pediatric nonrhabdomyosarcoma soft tissue sarcomas.
    Ferrari A; Casanova M
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):307-18. PubMed ID: 15877527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant chemotherapy in localized soft tissue sarcomas: still not proven.
    Blay JY; Le Cesne A
    Oncologist; 2009 Oct; 14(10):1013-20. PubMed ID: 19808771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
    Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
    Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of soft tissue sarcomas of the extremity in adults.
    Valle AA; Kraybill WG
    J Surg Oncol; 1996 Dec; 63(4):271-9. PubMed ID: 8982374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective randomized trials demonstrating the efficacy of adjuvant chemotherapy in adult patients with soft tissue sarcomas.
    Rosenberg SA
    Cancer Treat Rep; 1984 Sep; 68(9):1067-78. PubMed ID: 6383604
    [No Abstract]   [Full Text] [Related]  

  • 40. Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial.
    Le Cesne A; Blay JY; Domont J; Tresch-Bruneel E; Chevreau C; Bertucci F; Delcambre C; Saada-Bouzid E; Piperno-Neumann S; Bay JO; Mir O; Ray-Coquard I; Ryckewaert T; Valentin T; Isambert N; Italiano A; Clisant S; Penel N
    Lancet Oncol; 2015 Mar; 16(3):312-9. PubMed ID: 25680558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.